ArticleFrontiers in pharmacology2024

Decursinol angelate relieves inflammatory bowel disease by inhibiting the ROS/TXNIP/NLRP3 pathway and pyroptosis.

Yudi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.